LONDON/NEW YORK, June 9 (Reuters) - U.S. healthcare IT company Allscripts plans to buy rival Eclipsys in a $1.3 billion all-stock deal to capitalize on a huge influx of U.S. government funding for ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
The costs of integrating the ambulatory and acute expertise of Allscripts and Eclipsys may outweigh the synergies of combining the two companies.When HITECH passed with the American Recovery and ...
Shares of Allscripts Healthcare Solutions, Inc. MDRX fell 8.8% till May 9, following the company's first-quarter 2022 results announcement on May 5. Allscripts delivered adjusted earnings per share ...
Allscripts Healthcare Solutions, Inc. MDRX delivered adjusted earnings per share (EPS) of 79 cents in the fourth quarter of 2021, up 295% year over year. The figure surpassed the Zacks Consensus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results